Columbia Laboratories Inc.  

(Public, NASDAQ:CBRX)   Watch this stock  
Find more results for MHJP, Inc
-0.01 (-0.13%)
Real-time:   3:04PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 7.42 - 7.75
52 week 5.09 - 7.99
Open 7.52
Vol / Avg. 58,363.00/53,236.00
Mkt cap 80.90M
P/E 15.42
Div/yield     -
EPS 0.49
Shares 10.77M
Beta 0.90
Inst. own 24%
Feb 9, 2015
Columbia Laboratories Inc at Biotechnology Industry Organization CEO & Investor Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 32.02% 22.94%
Operating margin 30.64% 20.10%
EBITD margin - 28.80%
Return on average assets 27.52% 13.83%
Return on average equity 35.51% 17.07%
Employees 77 -
CDP Score - -


United States - Map
+1-973-4868820 (Phone)
+1-617-4820618 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Columbia Laboratories, Inc. (Columbia) is engaged in the development and analysis of pharmaceuticals, clinical trial manufacturing of pharmaceutical products for pharmaceutical company customers and the potential development of pharmaceuticals. The Company seeks to research and develop new therapeutic entities utilizing its drug delivery technology for licensing to pharmaceutical companies for commercialization. The Company is focused on the supply of CRINONE to its marketing partner and providing pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry through its wholly owned subsidiary, Molecular Profiles Limited. It has developed and brought to market five bioadhesive vaginal gel products, each commercialized through alliances. All the products developed by the Company utilize its Bioadhesive Delivery System (BDS), which consists of a polymer (polycarbophil) and an active ingredient.

Officers and directors

Stephen Garfield Kasnet Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Frank C. Condella Jr. President, Chief Executive Officer, Director
Age: 59
Bio & Compensation  - Reuters
George O. Elston CPA Chief Financial Officer
Age: 50
Bio & Compensation  - Reuters
Bridget A Martell Chief Medical Officer
Age: 49
Bio & Compensation  - Reuters
Donald H. Hunter Director
Age: 58
Bio & Compensation  - Reuters
Nikin Patel Director
Age: 41
Bio & Compensation  - Reuters
Valerie L. Andrews Independent Director
Age: 55
Bio & Compensation  - Reuters
Frank Murdoch Armstrong Independent Director
Age: 56
Bio & Compensation  - Reuters
Cristina Csimma Pharm.D., M.H.P. Independent Director
Age: 55
Bio & Compensation  - Reuters